About Professor Georgina Long AO and Professor Richard Scolyer AO
Key info:
- Revolutionary Treatment: Their research into immunotherapy has significantly increased survival rates for advanced melanoma patients.
- Global Leadership: Based at Melanoma Institute Australia, they lead international clinical trials and research, as highlighted on the Australian of the Year Awards website.
- Cancer Innovation: Prof Scolyer is the first brain cancer patient to receive a personalized, brain-tumor-specific immunotherapy based on their research, a groundbreaking move monitored in scientific studies published in early 2025, according to SMH.com.au.
- Advocacy: They are strong proponents of sun-safe behavior, targeting Australia’s tanning culture to prevent melanoma
Professor Georgina Long AO and Professor Richard Scolyer AO categories:
Professor Georgina Long AO and Professor Richard Scolyer AO’s enduring partnership has saved thousands of lives from melanoma, known as Australia’s national cancer.
Less than a decade ago, advanced melanoma was fatal – but thanks to advances in immunotherapy that activate a patient’s own immune system, it has become a curable disease.
The co-medical directors of Melanoma Institute Australia are sought-after media commentators and advocates for sun-safe behaviour and melanoma prevention.
In June 2023, when Richard was diagnosed with incurable Grade 4 brain cancer, Georgina developed a series of world-first treatments based on melanoma breakthroughs.
Richard became the world’s first brain cancer patient to have pre-surgery combination immunotherapy, an experimental treatment hoping to advance the understanding of brain cancer.
Richard has generated widespread public interest by documenting his cancer journey.
Enquire for Professor Georgina Long AO and Professor Richard Scolyer AO for your next event.
Browse more speakers: HERE
Related Speakers
